Our laboratory has reported that ILK inhibition in a mouse model of colitis blocked NF-κB (IKK and p65) activation, and suppressed TNF-α, IL-6, and IL-1β production as well as infiltration of inflammatory cells (Ahmed et al., 2014, 2017). Here, NFKB1 is linked to colitis.